Balazs Szamosfalvi, MD
Associate Professor of Internal Medicine and Medical Director
MDS
Internal Medicine
[email protected]

Available to mentor
Balazs Szamosfalvi, MD
Clinical Associate Professor
  • Qualifications
  • Center Memberships
  • Recent Publications
    • Qualifications
    • MD
      Semmelweis University School of Medicine, Ulloi ut 26, 1993
    Center Memberships
    • Center Member
      Center for Integrative Research in Critical Care
    Recent Publications See All Publications
    • Presentation
      Advances in continuous, non-invasive hemodynamic monitoring during CRRT ultrafiltration
      Szamosfalvi B. 2024 May 29;
    • Presentation
      Optical Sensors with Truly Regional Citrate Anticoagulation: Rationale, Implementation and Prospects
      Szamosfalvi B. 2024 Mar;
    • Journal Article
      Citrate Anticoagulation for CKRT with Liver Failure: Ready for Prime Time?
      Szamosfalvi B, Heung M. Clin J Am Soc Nephrol, 2024 Feb 1; 19 (2): 139 - 141. DOI:10.2215/CJN.0000000000000390
      PMID: 38109078
    • Proceeding / Abstract / Poster
      Role of Immunomodulation Therapy with Selective Cytopheretic Device (SCD) in Reversing Acute on Chronic Liver Failure (ACLF) with Hepatorenal Syndrome (HRS) and Multi-Organ Failure
      Yessayan LT, Sharma P, Westover A, Szamosfalvi B, Humes HD. Journal of the American Society of Nephrology, 2023 Nov 1; 34 (11S): 443 - 443. DOI:10.1681/asn.20233411s1443c
    • Presentation
      Fixed Flow Ratio (FFR)-CKRT-RCA for AKI: From Empiricism to Precision Medicine
      Szamosfalvi B. 2023 Oct;
    • Journal Article
      Extracorporeal Immunomodulation Therapy in Acute Chronic Liver Failure With Multiorgan Failure: First in Human Use.
      Yessayan LT, Sharma P, Westover AJ, Szamosfalvi B, Humes HD. ASAIO J, 2024 Mar 1; 70 (3): e53 - e56. DOI:10.1097/MAT.0000000000002033
      PMID: 37643314
    • Journal Article
      Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human.
      Humes HD, Aaronson KD, Buffington DA, Sabbah HN, Westover AJ, Yessayan LT, Szamosfalvi B, Pagani FD. PLoS One, 2023 18 (4): e0273138 DOI:10.1371/journal.pone.0273138
      PMID: 37023139
    • Preprint
      Translation of Immunomodulatory Therapy to Treat Chronic Heart Failure: Preclinical Studies to First in Human
      Humes HD, Aaronson KD, Buffington D, Sabbah HN, Westover AJ, Yessayan LT, Szamosfalvi B, Pagani FD. medRxiv, DOI:10.1101/2022.08.19.22278416